Search Results
Mar 02, 2026, 17:46 ET Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
drivers, market barriers, and key epilepsy companies, including Xenon Pharmaceuticals, Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Takeda, Ovid Therapeutics, SK Biopharmaceuticals (SK Life Science), Eisai, Biohaven Pharmaceuticals, Knopp Biosciences, UCB Pharma, Alexza Pharmaceuticals, Neurocrine
More news about: DelveInsight Business Research LLP
Feb 24, 2026, 17:31 ET Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight
drivers, market barriers, and key epilepsy companies, including Xenon Pharmaceuticals, Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Takeda, Ovid Therapeutics, SK Biopharmaceuticals (SK Life Science), Eisai, Biohaven Pharmaceuticals, Knopp Biosciences, UCB Pharma, Alexza Pharmaceuticals, Neurocrine
More news about: DelveInsight Business Research, LLP
Nov 20, 2025, 12:30 ET Folger Theatre Announces the Plays and Playwrights for the Fourth Annual Reading Room Festival
debut. Director: Shakespeare Theatre Company Academy: East of the Sun, West of the Moon;The Odyssey; Cymbeline; Romeo and Juliet; Tales from Ovid; Hamlet (Radio); Pericles; The Maid's Tragedy; Great River Shakespeare Festival (Founding Artistic Director): A Midsummer Night's Dream,Othello,
More news about: Folger Shakespeare Library
Oct 29, 2025, 08:30 ET Miami Biotech Collective Introduces Board of Advisors and Women's Leadership Council to Shape South Florida's Biotech Future
Collective, is a biopharma executive with over 20 years of experience across biotech and medtech. She has held strategic senior leadership roles at Ovid Therapeutics, GE Healthcare, Medtronic, and Columbia University Medical Center, and advises multiple non-profits.
More news about: Miami Biotech Collective
Oct 20, 2025, 11:00 ET Resistance to Epilepsy Treatments May Wane Over Time
Neurocrine Biosciences, Neurona Therapeutics, NeuroPace, NeuroPro Therapeutics, Neuroventis, Neurvati, Noema Pharma, Ono Pharmaceutical Co., Otsuka, Ovid Therapeutics, Praxis Precision Medicines, PureTech Health, Rapport Therapeutics, Receptor Holdings, RiverVest, Sage Therapeutics, SK Life Science, Stoke
More news about: NYU Grossman School of Medicine and NYU Langone Health
Oct 15, 2025, 09:00 ET Benchmark Wine Group to Present The Weiss Collection: A Landmark Napa and Rare Spirits Cellar
2017, they described it as "constructed around his California Cabernet-centric holdings," filled with the great names of Napa Valley: Continuum, Ovid, and Phelps Insignia. Over the years, Weiss expanded his focus, building a cellar that reflects both his deep connection to Napa and a growing curiosity
More news about: Benchmark Wine Group
Aug 25, 2025, 11:00 ET Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief
Neurocrine Biosciences, Neurona Therapeutics, NeuroPace, NeuroPro Therapeutics, Neuroventis, Neurvati, Noema Pharma, Ono Pharmaceutical Co., Otsuka, Ovid Therapeutics, Praxis Precision Medicines, PureTech Health, Rapport Therapeutics, Receptor Holdings Inc., RiverVest, Sage Therapeutics, SK Life Science,
More news about: NYU Grossman School of Medicine and NYU Langone Health